Brief: TransCode Therapeutics Announces Withdrawal Of Registration Statement
06/12/2022 21:26
Dec 6 (Reuters) - Transcode Therapeutics Inc RNAZ.O :
* TRANSCODE THERAPEUTICS ANNOUNCES WITHDRAWAL OF
REGISTRATION
STATEMENT
* TRANSCODE THERAPEUTICS INC - WITHDREW REGISTRATION
STATEMENT ON
FORM S-1 IT FILED WITH U.S. SECURITIES AND EXCHANGE COMMISSION
ON NOVEMBER 28, 2022
Source text for Eikon: ID:nGNXc10DNJ
Further company coverage: RNAZ.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Transcode Therapeutics
See all newsBrief: TransCode Therapeutics Appoints John Tattory As Interim CFO
Brief: Transcode Therapeutics Appoints Dr. Anna Moore As Chair Of Scientific Advisory Board
Brief: Transcode Therapeutics Inc - Enters Exclusive License Agreement With Unleash
Brief: Transcode Therapeutics Ttx-Mc138 Phase 2A Clinical Trial Expected In First Half Of 2026
Brief: Transcode Therapeutics Expands Leadership With Appointment Of Jack E. Stover To Board Of Directors